<DOC>
	<DOCNO>NCT00310219</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure , positron emission tomography ( PET ) scan CT scan , may help doctor plan radiation therapy patient non-small cell lung cancer . PURPOSE : This clinical trial study well combine PET scan CT scan work compare CT scan alone plan radiation therapy patient stage II stage III non-small cell lung cancer .</brief_summary>
	<brief_title>Positron Emission Tomography Scan CT Scan Planning Radiation Therapy Patients With Stage II Stage III Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine impact positron emission tomography ( PET ) /CT fusion scan CT scan alone , compare gross tumor volume ( GTV ) contour three-dimensional conformal radiotherapy treatment plan use 2 separate data set ( PET/CT fusion scan CT scan ) , patient stage II III non-small cell lung cancer plan undergo radiotherapy . - Determine impact PET GTV ( cm^3 ) , number involve node , location involve node , dosimetric measure normal tissue toxicity ( mean lung dose , V20 , mean esophageal dose ) . Secondary - Determine rate elective nodal failure ( nodal failure region intentionally irradiate definitive dos [ i.e. , ipsilateral hilum , mediastinum , ipsilateral supraclavicular fossa ] ) . OUTLINE : This multicenter study . Patients stratify accord neoadjuvant chemotherapy ( yes v ) . Patients undergo combine positron emission tomography ( PET ) /CT scan . Patients also undergo CT scan alone . A single three-dimensional conformal radiotherapy ( 3DCRT ) plan generate combined PET/CT scan result . A single 3DCRT plan use plan target volume derive CT scan . Patients follow every 3 month 1 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 48 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm nonsmall cell lung cancer ( NSCLC ) Stage IIA/IIB stage IIIA/IIIB disease Planning undergo radiotherapy Local regional nodal recurrence surgery allow No malignant pleural effusion PATIENT CHARACTERISTICS : Zubrod performance status 02 Negative pregnancy test Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : See Disease Characteristics Concurrent neoadjuvant and/or concurrent chemotherapy allow No concurrent intensitymodulated radiotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
</DOC>